Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health. | Cells | 2023 | 37887306 | PubTator, text mining | PubMed |
| SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2023 | 37876546 | PubTator, text mining | PubMed |
| Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer. | Anal Cell Pathol (Amst) | 2023 | 37868825 | PubTator, text mining | PubMed |
| Physiological Replication of the Human Glomerulus Using a Triple Culture Microphysiological System. | Adv Sci (Weinh) | 2023 | 37867234 | PubTator, text mining | PubMed |
| High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression. | Sci Rep | 2023 | 37863991 | PubTator, text mining | PubMed |
| Vitamin D status associates with skeletal muscle loss after anterior cruciate ligament reconstruction. | JCI Insight | 2023 | 37856482 | PubTator, text mining | PubMed |
| A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer. | Cancer Drug Resist | 2023 | 37842240 | PubTator, text mining | PubMed |
| Epigenetic Biomarkers of Metabolic Responses to Lifestyle Interventions. | Nutrients | 2023 | 37836535 | PubTator, text mining | PubMed |
| Exogenous Ketone Supplementation and Ketogenic Diets for Exercise: Considering the Effect on Skeletal Muscle Metabolism. | Nutrients | 2023 | 37836512 | PubTator, text mining | PubMed |
| Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease. | Diagnostics (Basel) | 2023 | 37835901 | PubTator, text mining | PubMed |
| Effects of Weight Loss and Aerobic Exercise Training on Adi-Pose Tissue Zinc α2-Glycoprotein and Associated Genes in Obesity. | Cells | 2023 | 37830580 | PubTator, text mining | PubMed |
| Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis. | Transl Neurodegener | 2023 | 37828541 | PubTator, text mining | PubMed |
| Single-Nuclei RNA-Sequencing of the Gastrocnemius Muscle in Peripheral Artery Disease. | Circ Res | 2023 | 37823262 | PubTator, text mining | PubMed |
| Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease. | Front Immunol | 2023 | 37809060 | PubTator, text mining | PubMed |
| Effects of two different paradigms of electrical stimulation exercise on cardio-metabolic risk factors after spinal cord injury. A randomized clinical trial. | Front Neurol | 2023 | 37808500 | PubTator, text mining | PubMed |
| ERRα fosters running endurance by driving myofiber aerobic transformation and fuel efficiency. | Mol Metab | 2023 | 37802398 | PubTator, text mining | PubMed |
| A PrP EGFR signaling axis controls neural stem cell senescence through modulating cellular energy pathways. | J Biol Chem | 2023 | 37802314 | PubTator, text mining | PubMed |
| Human model of primary carnitine deficiency cardiomyopathy reveals ferroptosis as a novel mechanism. | Stem Cell Reports | 2023 | 37802072 | PubTator, text mining | PubMed |
| ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis. | Open Life Sci | 2023 | 37800117 | PubTator, text mining | PubMed |
| Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37787988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=18